한빛사314건

• • Terrence T. Roh(University of Illinois Urbana-Champaign, GSK plc)

  Predicting DNA damage response in non-small cell lung cancer organoids via simultaneous label-free autofluorescence multiharmonic microscopy

  • Redox Biol. Sep 2024, 75 103280 S2213-2317(24)00258-1 | https://doi.org/10.1016/j.redox.2024.103280

  • 2024.09

• • 이종원(한국과학기술연구원(KIST))

  • 양유수(한국과학기술연구원(KIST))

  • 김선화(한국과학기술연구원(KIST))

  Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy

  • ACS Nano Aug 08 2024, | https://doi.org/10.1021/acsnano.4c06471

  • 2024.08
  • 바이오·의료융합

• • 전태원(Massachusetts Institute of Technology)

    Interview

  Engineered Zwitterionic Diblock Copolymer-siRNA Polyplexes Provide Highly Effective Treatment of Triple-Negative Breast Cancer in a 4T1 Murine Model

  • Adv. Funct. Mater. 01 August 2024 | https://doi.org/10.1002/adfm.202406763

  • 2024.08
  • 바이오·의료융합

• • 김률(Inocras Inc.)

  • 김석휘(아주대학교 의과대학)

  • 오백록(Inocras Inc.)

  • 주영석(Inocras Inc.)

  • 권민석(아주대학교병원 종양혈액내과, 삼성서울병원 혈액종양내과)

  Clinical application of whole-genome sequencing of solid tumors for precision oncology

  • Exp. Mol. Med. 13 August 2024 | https://doi.org/10.1038/s12276-024-01288-x

  • 2024.08
• 

  성예원

  NIH

  We study cisplatin, which is a widely used and effective anticancer drug, but it has significant side effects, including ototoxicity (hearing loss) and nephrotoxicity (kidney injury), in pediatric and adult cancer patients. In this paper, we investigated the role of macrophages in cisplatin-induced hearing loss and kidney injury in mice.

  • Sci. Adv.
  • 2024.08.21

• • 윤주영(이화여자대학교)

  Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: The Development and Application of BODIPY@F127 Nanoparticles

  • Adv. Healthc. Mater. Jul 28 2024, | https://doi.org/10.1002/adhm.202401981

  • 2024.07

• • 이수현(유빅스테라퓨틱스, 연세대학교)

  • 김화연(연세대학교)

  • 노재석(연세대학교)

  • 송재환(연세대학교)

  • 이송희(유빅스테라퓨틱스)

  UBX-390: A Novel Androgen Receptor Degrader for Therapeutic Intervention in Prostate Cancer

  • Adv. Sci. Jul 03 2024, | https://doi.org/10.1002/advs.202400398

  • 2024.07
  • 생명과학

• • 채영광(Northwestern University Feinberg School of Medicine)

  Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

  • J. Immunother. Cancer Jul 27 2024, 12 (7) e009074 | https://doi.org/10.1136/jitc-2024-009074

  • 2024.07
  • 의약학

• • 전흥진(충남대학교)

  • 임대진(강원대학교 의생명과학대학 의생명융합학부)

  • 정재호(전남대학교 의과대학)

  • 송미령(한국외국어대학교)

  • 이효진(충남대학교 의과대학, 충남대학교병원)

  Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers

  • Acta Pharm. Sin. B Available online 10 July 2024 | https://doi.org/10.1016/j.apsb.2024.07.011

  • 2024.07
  • 의약학
• 

  최재혁

  Northwestern University

  In brief, we found that a chemical imbalance that mechanistically explains a cellular imbalance in patients with lupus (compared to healthy controls). Correcting this chemical imbalance appears to be a useful therapeutic approach for this disease.

  • Nature
  • 2024.07.15

• • 설유진(강원대학교)

  • Keya Ganguly(강원대학교)

  • 임기택(강원대학교)

  Stimuli-triggered pollen-inspired micro/nanorobots for advanced therapeutics

  • Nano Today Available online 3 June 2024 | https://doi.org/10.1016/j.nantod.2024.102337

  • 2024.06
  • 바이오·의료융합

• • My-Van Tieu(가천대학교)

  • Duc-Trung Pham(가천대학교)

  • 조성보(가천대학교)

  Bacteria-based cancer therapy: Looking forward

  • Biochim. Biophys. Acta-Rev. Cancer May 16 2024, S0304-419X(24)00043-X | https://doi.org/10.1016/j.bbcan.2024.189112

  • 2024.05

• • 조영석(University of Michigan)

  • James J. Moon(University of Michigan)

  Novel strategies for modulating the gut microbiome for cancer therapy

  • Adv. Drug Deliv. Rev. May 15 2024, 210 S0169-409X(24)00154-6 | https://doi.org/10.1016/j.addr.2024.115332

  • 2024.05
  • 의약학

• • 박지은(고려대학교)

  • 김동휘(고려대학교)

  Advanced Immunomodulatory Biomaterials for Therapeutic Applications

  • Adv. Healthc. Mater. May 08 2024, | https://doi.org/10.1002/adhm.202304496

  • 2024.05
  • 생명과학

• • 이상아(Memorial Sloan Kettering Cancer Center)

  • 이기범(Rutgers, The State University of New Jersey)

  Developing miR-133a Zipper Nanoparticles for Targeted Enhancement of Thermogenic Adipocyte Generation

  • Adv. Healthc. Mater. May 25 2024, | https://doi.org/10.1002/adhm.202400654

  • 2024.05
  • 바이오·의료융합

• • 최주희(Washington University School of Medicine in St. Louis)

  Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study

  • EClinicalMedicine May 2024, 71 102490 | https://doi.org/10.1016/j.eclinm.2024.102490

  • 2024.05

• • 정다정(서울아산병원 의생명연구소)

  • 최종우(울산대학교 의과대학, 서울아산병원)

  • 정기석(울산대학교 의과대학, 서울아산병원)

  [Correspondence] Generation of sarconoids from angiosarcoma patients as a systematic-based rational approach to treatment

  • J. Hematol. Oncol. May 20 2024, 17 (1) | https://doi.org/10.1186/s13045-024-01556-3

  • 2024.05
  • 바이오·의료융합

• • Vijaya Sunkara(UNIST)

  • 조윤경(UNIST)

  The Role of Extracellular Vesicles in the Treatment of Prostate Cancer

  • Small Apr 19 2024, | https://doi.org/10.1002/smll.202311071

  • 2024.04
  • 바이오·의료융합

• • 문슬기(국립순천대학교)

  • 심현보(국립순천대학교)

  • 이재혁(한국기초과학지원연구원)

  • 이성수(한국기초과학지원연구원)

  • 장동조(국립순천대학교)

  • 김종진(국립순천대학교)

  Targeting Heme Oxygenase 2 (HO2) with TiNIR, a Theragnostic Approach for Managing Metastatic Non-Small Cell Lung Cancer

  • Biomater. Res. 25 Apr 2024 Vol 28, Article ID: 0026 | https://doi.org/10.34133/bmr.0026

  • 2024.04
  • 생명과학

• • 이유진(UNIST, KAIST)

  • 채영찬(UNIST)

  Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer

  • Exp. Mol. Med. 05 April 2024 | https://doi.org/10.1038/s12276-024-01209-y

  • 2024.04
  • 생명과학